Company intelligence
Nuvisan
From discovery to the clinic and beyond
About Nuvisan
Your partner of choice in bringing therapeutics to life, Nuvisan is the unique CRO/CDMO with extensive pharma experience and industry-leading scientific expertise, providing highest-quality end-to-end solutions. From enabling target understanding to helping get innovative medicines to the patients who need them, we provide support that streamlines and accelerates drug discovery and development.
Verified activity
Signals from Nuvisan
7 published signals
Presence & Recognition
Nuvisan is exhibiting at the EFMC 2026 event in Basel at Booth 14 to discuss medicinal chemistry, custom synthesis, lead optimisation, microbiological chemistry, direct-to-biology, route scouting, process development, and scale-up.
Reported by Nuvisan
Presence & Recognition
Nuvisan is attending CPHI Milan 2026 to discuss small molecule API/HPAPI process development, analytical support, formulation, clinical manufacturing, clinical trial supply, and EU QP release alongside colleagues from ALS.
Reported by Nuvisan
Presence & Recognition
Nuvisan is presenting at the EFMC-ISMC that started in Basel on Wednesday morning about one of their exciting Womens Health projects.
Reported by Stefan Werner
Presence & Recognition
Nuvisan is attending the CPHI event around the corner.
Reported by Guillaume B.
Research & Knowledge
Nuvisan has completed over 15 HTX projects across a diverse range of protein classes over the past year, achieving hit rates from 4% to 40% depending on target druggability.
Reported by Nuvisan
Operations & Supply
Nuvisan is strengthening its European–Indian hybrid model with a new ALS synthesis laboratory in Hyderabad.
Reported by Nuvisan
People
Nuvisan is looking for a Chemielaborant in the Munich location for a full-time, unqualified contract position.
Reported by Rosa Lavaccara-Tuna